{"id":"tp-41328","type":"article-newspaper","title":"Wave Life Sciences Sets Oct. 27, 2026 Q3 Review, Expects WVE-006 Data in Q4 2026","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/41328","datePublished":"2026-10-26T21:00:27.000Z","dateModified":"2026-10-26T21:00:27.000Z","language":"en","abstract":"Cash, cash equivalents and marketable securities totaled $490.6 million at June 30, with the balance expected to fund operations into the third quarter of 2028.","section":"Business","references":[]}